NCT04233515View on ClinicalTrials.gov

Use of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in Örebro County

CompletedOBSERVATIONAL
Enrollment

11,964

Participants

Timeline

Start Date

September 2, 2019

Primary Completion Date

January 29, 2021

Study Completion Date

January 29, 2021

Conditions
Atrial FibrillationStroke, Ischemic
Interventions
DRUG

Oral anticoagulant

Clinical visit to a physician to assess stroke and bleeding risk and to possibly initiate OAC therapy or refer for left atrial appendage occlusion

Trial Locations (1)

70185

Department of cardiology, Örebro

All Listed Sponsors
lead

Region Örebro County

OTHER

NCT04233515 - Use of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in Örebro County | Biotech Hunter | Biotech Hunter